NSTENon-ST-Segment Elevation (type of heart attack; describes EKG)
NSTENorth Shore Temple Emanuel (Australia)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
ACE inhibitors SHOULD be given-unless contraindicated-within the first day of admission and continued indefinitely for NSTE ACS patients with: 1.
"The results of our study, taken together with the results of previous larger trials, suggest that the results from men do not necessarily apply to women and that large-scale randomized trials in women are needed to determine the optimal strategy in NSTE ACS," said Dr.
He presented an analysis of CRUSADE quality improvement registry data involving 138,714 patients with non-ST-elevation acute coronary syndrome (NSTE ACS) treated at 547 U.S.
[6] Nonstandard abbreviations: AMI, acute myocardial infarction; cTns, cardiac troponins; ACS, acute coronary syndrome; NSTE, non-STelevation; NT-proBNP, amino-terminal pro-B-type natriuretic peptide; NSTEMI, non-STelevation myocardial infarction; UAP, unstable angina pectoris; ECG, electrocardiography; CAD, coronary artery disease; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; LoD, limit of detection; eGFR, estimated glomerular filtration rate; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; HF, heart failure; AUC, area under the ROC curve; CRP, C-reactive protein; HR, hazard ratio; IMD, intermethod dispersion.
Quantitative troponin and death, cardiogenic shock, cardiac arrest and new heart failure in patients with non-STsegment elevation acute coronary syndromes (NSTE ACS): insights from the Global Registry of Acute Coronary Events.
In fact, her new meta-analysis raises the possibility that women with non-ST-elevation acute coronary syndrome (NSTE ACS) are more likely to be harmed than helped by such an approach.
Data from the CRUSADE national quality-improvement registry indicate nearly 30% of patients hospitalized with non-ST segment elevation acute coronary syndrome (NSTE ACS) receive intravenous morphine within the first 24 hours of presentation.
With NSTE ACS patients accounting for more than 1 million hospital admissions per year in the United States, the CRUSADE evidence for often-suboptimal management of the large portion managed solely medically is an "incredibly important" concern, he added.
In an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation (EARLY) ACS and Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial databases, among non-ST-segment elevation (NSTE) ACS patients who had a decreasing or stable CK-MB pattern before PCI, and thus had the post-PCI biomarkers interpretable, nearly 65% had a new increase of CK-MB post-PCI (9).